# Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma

> **NCT03789123** · PHASE4 · UNKNOWN · sponsor: **Bagcilar Training and Research Hospital** · enrollment: 710 (estimated)

## Conditions studied

- Ovarian Reserve

## Interventions

- **DRUG:** Estradiol valerate/dienogest

## Key facts

- **NCT ID:** NCT03789123
- **Lead sponsor:** Bagcilar Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 710 (ESTIMATED)
- **Last updated:** 2018-12-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789123, "Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03789123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*